Avanos Medical, Inc. (FRA:8HH)

Market Cap	609.13M -14.9%
Revenue (ttm)	596.52M +2.7%
Net Income	-399.64M
EPS	-8.65
Shares Out	n/a
PE Ratio	n/a
Forward PE	16.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,261
Average Volume	n/a
Open	12.80
Previous Close	12.70
Day's Range	12.80 - 12.80
52-Week Range	8.50 - 14.90
Beta	n/a
RSI	72.44
Earnings Date	Feb 24, 2026

About Avanos Medical

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2014
• Employees: 2,227
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8HH

Financial Performance

In 2024, Avanos Medical's revenue was $687.80 million, an increase of 2.15% compared to the previous year's $673.30 million. Losses were -$392.10 million, 534.5% more than in 2023.

Financial numbers in USD